Patients with high expression of PTTG1 were associated with poor disease-free survival (DFS) in the ACC, KIRC, KIRP, LGG, LIHC, MESO, PAAD, PRAD, SARC, and UVM (Figure 5B). This evidence concerns the gene PTTG1 and adrenal cortex carcinoma.